Clinical Trial Update: Carvedilol in HF With Preserved EF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating carvedilol in heart failure with preserved ejection fraction (HFpEF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Heart Failure With Preserved Ejection Fraction, Beta Blocker | Phase 4 | Status: UNKNOWN